Sort
40,608 grants matching “prostate cancer”
Breaking down tumor immune privilege through targeted hypoxia reduction
$472,058Michael A. Curran · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Breaking down tumor immune privilege through targeted hypoxia reduction
$472,058Michael A. Curran · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Molecular Analysis of Cancer--Imaging Mass Spectrometry
$472,000Vanderbilt University · R33 · FY2002 · CA
Basic and Translational Research Center for Reducing Health Disparities
$471,977Jesus Alexander Angulo · Hunter College · G12 · FY2017 · MD
Mitigating Cancer Treatment-Related Fatigue by Exercise
$471,921Johns Hopkins University · R01 · FY2002 · NR
B7-H1/PD-1 modulation in cancer therapy
$471,842Drew M. Pardoll · Johns Hopkins University · R01 · FY2012 · CA
The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer
$471,840Lewis C Cantley · Beth Israel Deaconess Medical Center · P01 · FY2010 · CA
Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards
$471,721Gregory S Karczmar · University Of Chicago · R01 · FY2013 · CA
A First-in-Class FAP-activated Protoxin to disrupt the Tumor-Stroma Parasitic Cycle fueling lethal Prostate Cancer Progression
$471,718William Nathaniel Brennen · Johns Hopkins University · R01 · FY2021 · CA
Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence
$471,586Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence
$471,586Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Novel Non-Peptide Antagonists of the GnRH Receptor
$471,580Neurocrine Biosciences, Inc. · R44 · FY2001 · HD
Novel Non-Peptide Antagonists of the GnRH Receptor
$471,580Neurocrine Biosciences, Inc. · R44 · FY2002 · HD
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE
$471,578University Of North Carolina Chapel Hill · R01 · FY2005 · CA
Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling
$471,503Hsian-Rong Tseng · University Of California Los Angeles · U01 · FY2016 · CA
Resolving ensemble averaged conformations by multi-temperature x-ray crystallography
$471,468James Solomon Fraser · University Of California, San Francisco · R01 · FY2019 · GM
Co-evolution of the Reactive Microenvironment in Prostate Cancer Progression
$471,453David R Rowley · Baylor College Of Medicine · U54 · FY2010 · CA
SEQUENCING TUMOR SUPPRESSOR LOCI
$471,428Cold Spring Harbor Laboratory · R01 · FY2003 · CA
DEVELOPMENTAL FUNDS
$471,426Paul A Bunn · University Of Colorado Denver · P30 · FY2016 · CA
Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination thru Engagement in Mindfulness Education (REASSURE ME)
$471,385David Victorson · Northwestern University At Chicago · R01 · FY2020 · CA
Hyaluronan Receptors in Prostate Cancer Progression
$471,291James B. McCarthy · University Of Minnesota · R01 · FY2009 · CA
Engagement Optimization Unit
$471,205Jennifer W Mack · Broad Institute, Inc. · U2C · FY2021 · CA
Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy
$471,200Yu Chen · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA
Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiation
$471,199Jin Xie · University Of Georgia · R01 · FY2020 · EB
Efficacy of a Couple-focused, Tailored, Symptom Self-Management mHealth Intervention for Prostate Cancer Patients and Partners
$471,163Lixin Song · Univ Of North Carolina Chapel Hill · R01 · FY2021 · NR